Company Snapshot
888 3rd Street SW
Calgary, AB T2P 5C5
Canada
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 6
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
-$4,638,175
-$2,616,470
-$5,211,809
Net Income
-$19,890,272
-$8,832,499
-$8,531,020
2020
Gross Profit
Operating Income
-$4,638,175
Net Income
-$19,890,272
2021
Gross Profit
Operating Income
-$2,616,470
Net Income
-$8,832,499
2022
Gross Profit
Operating Income
-$5,211,809
Net Income
-$8,531,020
The above data on Cannapharmarx Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
President, Chief Executive Officer, Chief Financial Officer and Director
$60,000
$0
$60,000
$120,000
$120,000
President, Chief Executive Officer, Chief Financial Officer and Director
Cannapharmarx Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2012. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us